These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


274 related items for PubMed ID: 4611550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Controlled therapeutic study of 5 intermittent chemotherapy regimens for pulmonary tuberculosis. 4th international study of the UICT].
    Bignall JR.
    Bull Int Union Tuberc; 1974; 49(1):422-6. PubMed ID: 4143179
    [No Abstract] [Full Text] [Related]

  • 4. A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 2. Second report: the results from 12 to 24 months.
    Who Collaborating Centre For Tuberculosis Chemotherapy.
    Bull World Health Organ; 1973; 48(2):155-65. PubMed ID: 4578361
    [Abstract] [Full Text] [Related]

  • 5. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G, Gonin JD, Gubéran E, de Kalbermatten JP, Vulliémoz P, Willa C.
    Schweiz Med Wochenschr; 1969 Feb 01; 99(5):150-6. PubMed ID: 4974643
    [No Abstract] [Full Text] [Related]

  • 6. [Intermittent treatment and simplified continuous treatment of newly-detected pulmonary tuberculosis with first-line drugs and limited PAS administration. I. Methods and results].
    Stopczyk J, Niemirowska H, Pecyna-Sielewicz J, Janowiec M, Banaszkiewicz H, Czerwiński Z, Królikowska H, Krahowska M, Malecki S, Pezińska Z, Pilch Z, Przemyska B, Szustrowa I, Wardowa A.
    Gruzlica; 1973 Jul 01; 41(7):755-64. PubMed ID: 4730976
    [No Abstract] [Full Text] [Related]

  • 7. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G, Petitjean R, Schranz J, Scherrer B.
    Rev Tuberc Pneumol (Paris); 1970 Jul 01; 34(3):439-53. PubMed ID: 5515514
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I, Fujita S, Gomi J, Hibino S, Horai Z.
    Kekkaku; 1970 Aug 01; 45(8):257-62. PubMed ID: 4918166
    [No Abstract] [Full Text] [Related]

  • 9. [Results of the study "Intermittent therapy of tuberculosis within therapeutic health centers"].
    Cavić L, Kaleta J, Sazdanić D, Krstić M.
    Nar Zdrav; 1972 Aug 01; 28(7):230-5. PubMed ID: 4633209
    [No Abstract] [Full Text] [Related]

  • 10. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A, Maalej M, Zbiba M, El Gharbi T, El Mekki L, Chebbi ML, Djenayah F, Ben Salah M, El Gharbi B, Jeguirim M, Cherif M.
    Tunis Med; 1974 Aug 01; 52(6):305-11. PubMed ID: 4619936
    [No Abstract] [Full Text] [Related]

  • 11. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun 01; 48(6):235-45. PubMed ID: 4581528
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G, Lévy A, Guignon JP, Lecoq H, Friess JM, Maman P.
    Rev Tuberc Pneumol (Paris); 1969 Dec 01; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Proceedings: Significance and limits of controlled clinical research (in pulmonary tuberculosis)].
    Bignall JR.
    Z Erkr Atmungsorgane Folia Bronchol; 1973 Dec 01; 138(1):103-6. PubMed ID: 4588016
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of early detected destructive pulmonary tuberculosis].
    Anfilof'eva OIu, fedotova ZN.
    Probl Tuberk; 1974 Dec 01; (12):38-41. PubMed ID: 4445134
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A follow-up study of 134 cases of pulmonary tuberculosis treated with adequate chemotherapy in 1953-1954.
    Cheung OT, Pugsley HE.
    Can Med Assoc J; 1968 Jun 22; 98(25):1182-3. PubMed ID: 5657185
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Evaluation of high dose INH twice weekly regimen in the original treatment for moderately advanced pulmonary tuberculosis. A report of the 12th series B study of the controlled trials].
    Kekkaku; 1972 Jun 22; 47(6):159-66. PubMed ID: 4562924
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.